CAS Medical Systems, Inc. (CASM) Financial Statements (2024 and earlier)

Company Profile

Business Address 44 EAST INDUSTRIAL ROAD
BRANFORD, CT 06405
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:3,8625,1954,7625,6536,2894,839
Cash and cash equivalents3,8625,1954,7625,6536,2894,100
Other undisclosed cash, cash equivalents, and short-term investments      739
Receivables3,3582,9702,7052,9192,3292,545
Inventory, net of allowances, customer advances and progress billings1,3131,1649271,0761,5421,114
Inventory1,3131,1649271,0761,5421,114
Disposal group, including discontinued operation     626509
Other current assets414452333338413505
Other undisclosed current assets    15 (739)
Total current assets:8,9489,7818,72710,00111,1998,773
Noncurrent Assets
Property, plant and equipment1,9842,1432,1342,1712,3492,417
Intangible assets, net (including goodwill)8037647978028153
Intangible assets, net (excluding goodwill)8037647978028153
Regulated entity, other noncurrent assets      444
Other undisclosed noncurrent assets      364
Total noncurrent assets:2,7872,9072,9312,9733,1633,228
TOTAL ASSETS:11,73412,68811,65812,97514,36212,001
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,9702,8682,6012,3432,5022,388
Accounts payable9701,240852692740687
Accrued liabilities2,0001,6281,7481,6521,7621,701
Debt 68164   1,333
Other undisclosed current liabilities  3,0762,8552,0551,001
Total current liabilities:3,0383,0315,6775,1984,5564,722
Noncurrent Liabilities
Liabilities, other than long-term debt, including:400400320320320320
Other undisclosed liabilities, other than long-term debt400400320320320320
Other undisclosed noncurrent liabilities9,2179,1454,1834,9435,7066,484
Total noncurrent liabilities:9,6179,5454,5035,2636,0266,804
Total liabilities:12,65512,57610,18010,46210,58211,526
Equity
Equity, attributable to parent, including:(920)1111,4772,5133,780475
Common stock116115115114113113
Treasury stock, value(101)(101)(101)(101)(101)(101)
Additional paid in capital32,97132,72032,37131,98931,78131,565
Accumulated deficit(47,843)(46,560)(44,845)(43,427)(41,950)(45,039)
Other undisclosed equity, attributable to parent13,93813,93813,93813,93813,93813,938
Total equity:(920)1111,4772,5133,780475
TOTAL LIABILITIES AND EQUITY:11,73412,68811,65812,97514,36212,001

Income Statement (P&L) ($ in thousands)

12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
Revenues5,3825,2915,4445,1214,5264,572
Revenue, net5,3825,2915,4445,1214,5264,572
Cost of revenue(2,242)(2,111)(2,358)(2,368)(1,882)(2,194)
Cost of goods and services sold (2,242)(2,111)(2,358)(2,368)(1,882)(2,194)
Gross profit:3,1403,1813,0872,7542,6442,378
Operating expenses(4,116)(4,307)(4,233)(3,993)(3,937)(4,362)
Operating loss:(976)(1,126)(1,146)(1,239)(1,293)(1,983)
Nonoperating income (expense)    (4,388)4,3880
Investment income, nonoperating    (4,388)4,388 
Other nonoperating income    000
Interest and debt expense(308)(589)(272)(277)(275)(265)
Income (loss) from continuing operations before equity method investments, income taxes:(1,283)(1,715)(1,418)(5,905)2,820(2,248)
Other undisclosed income (loss) from continuing operations before income taxes    4,388(4,388) 
Loss from continuing operations before income taxes:(1,283)(1,715)(1,418)(1,516)(1,568)(2,248)
Income tax expense (benefit)    (37)1,63050
Other undisclosed income from continuing operations    3,980  
Income (loss) from continuing operations:(1,283)(1,715)(1,418)2,42662(2,198)
Income (loss) before gain (loss) on sale of properties:(1,283)(1,715)(1,418)2,5033,089(2,106)
Income from discontinued operations    773,02793
Net income (loss):(1,283)(1,715)(1,418)2,5033,089(2,106)
Other undisclosed net loss attributable to parent    (3,980)  
Net income (loss) attributable to parent:(1,283)(1,715)(1,418)(1,476)3,089(2,106)
Preferred stock dividends and other adjustments(429)(422)(415)(408)(401)(394)
Net income (loss) available to common stockholders, diluted:(1,713)(2,137)(1,833)(1,884)2,688(2,499)

Comprehensive Income ($ in thousands)

12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
Net income (loss):(1,283)(1,715)(1,418)2,5033,089(2,106)
Comprehensive income (loss), net of tax, attributable to parent:(1,283)(1,715)(1,418)2,5033,089(2,106)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: